Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Serum Albumin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Intestinal Neuroendocrine Tumor 1

Interventions

Cyclophosphamide 2678 Cisplatin 2644 Carboplatin 2457 Radiotherapy 2265 Paclitaxel 2252 Gemcitabine 2119 pembrolizumab 1958 Docetaxel 1859 Bevacizumab 1775 Fluorouracil 1538 Capecitabine 1509 Oxaliplatin 1428 Dexamethasone 1332 Nivolumab 1254 Doxorubicin 1249 Rituximab 1236 Etoposide 1131 Magnetic Resonance Spectroscopy 1054 Irinotecan 1040 Leucovorin 1021 Cytarabine 967 Drug Therapy 891 fludarabine 888 Pemetrexed 885 Vincristine 797 Lenalidomide 784 Prednisone 780 Cetuximab 772 Filgrastim 765 Specimen Handling 759

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡